BioXcel Therapeutics, Inc. Notes Payable, Related Parties, Current
BioXcel Therapeutics, Inc. (BTAI) had Notes Payable, Related Parties, Current of $371.00 thousand as of 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes
us-gaap:NotesPayableRelatedPartiesClassifiedCurrent · last filed 2019-03-12
- 2017-12-31: Notes Payable, Related Parties, Current $371.00K.
| Period end | Notes Payable, Related Parties, Current |
|---|---|
| 2017-12-31 | $371.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |